Gujarat Kidney & Super Speciality Ltd Falls 4.84%: Mixed Signals Shape Weekly Decline
2026-11-21 09:02:23Key Events This Week 16 Nov: Mojo grade downgraded to Hold amid mixed technical and valuation signals 18 Nov: Record quarterly performance reported despite 4.85% intraday drop 18 Nov: Technical momentum shifts to bullish from mildly bullish 19 Nov: Mojo grade downgraded again to Hold amid mixed financial and technical signals 20 Nov: Week closes at ₹148.60, down 4.84% for the week Week O...
Read More
Gujarat Kidney & Super Speciality Ltd Downgraded to Hold Amid Mixed Financial and Technical Signals
2026-11-19 08:41:20Gujarat Kidney & Super Speciality Ltd has seen its investment rating downgraded from Buy to Hold as of 18 Nov 2026, reflecting a nuanced assessment across quality, valuation, financial trends, and technical indicators. Despite outstanding quarterly financial results, concerns over valuation and mixed technical signals have tempered enthusiasm among investors.
Read More
Gujarat Kidney & Super Speciality Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
2026-11-19 08:06:29Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its MarketsMojo mojo grade from Buy to Hold as of 18 Nov 2026. Despite a strong year-to-date return of 48.03%, recent price action and technical indicators suggest a more cautious outlook for investors.
Read More
Gujarat Kidney & Super Speciality Ltd Reports Very Positive Financial Trend with Record Quarterly Performance
2026-11-18 16:00:08Gujarat Kidney & Super Speciality Ltd has delivered an impressive quarterly performance for September 2026, prompting MarketsMOJO to upgrade its rating from Hold to Buy. The hospital sector micro-cap demonstrated robust revenue growth, margin expansion, and record profitability metrics, signalling a very positive shift in its financial trend and investor sentiment.
Read More
Gujarat Kidney & Super Speciality Ltd is Rated Buy
2026-11-13 10:11:34Gujarat Kidney & Super Speciality Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 8 November 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 November 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreGujarat Kidney & Super Speciality Falls 4.68%: Mixed Signals Amid Strong Quarterly Growth
2026-11-07 09:01:46Key Events This Week 2 Nov: Downgrade to Hold amid valuation and technical concerns 2 Nov: Technical momentum shifts to mildly bullish with mixed signals 5 Nov: Q2 FY27 results show strong growth but raise valuation questions 6 Nov: Week closes at Rs.155.85, down 4.68% Week OpenRs.163.50 Week Close<div class="stat-val...
Read MoreGujarat Kidney & Super Speciality Ltd Falls 5.58%: Key Financial and Technical Developments This Week
2026-10-24 09:00:41Key Events This Week 19 Oct: Stock opens at Rs.188.25, up 0.45% despite Sensex decline 21 Oct: Price drops 2.28% amid broader market weakness 22 Oct: Technical and fundamental upgrades announced 23 Oct: Week closes at Rs.176.95, down 1.01% on final trading day Week OpenRs.187.40 Week CloseRs.17...
Read More
Gujarat Kidney & Super Speciality Ltd Upgraded to Buy on Strong Financial and Technical Signals
2026-10-23 08:45:15Gujarat Kidney & Super Speciality Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. The micro-cap hospital sector stock’s recent performance and robust fundamentals have prompted this positive reassessment by MarketsMOJO, signalling renewed investor confidence amid a challenging market backdrop.
Read More
Gujarat Kidney & Super Speciality Ltd is Rated Hold
2026-10-14 10:10:47Gujarat Kidney & Super Speciality Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 October 2026, providing investors with the latest insights into its performance and outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
11-Nov-2026 | Source : BSETranscript of Earning Call conducted on 05/11/2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
05-Nov-2026 | Source : BSEAudio recording of earning call
Announcement under Regulation 30 (LODR)-Newspaper Publication
05-Nov-2026 | Source : BSENewspaper publication for Unaudited Financial Statements for the Quarter ended September 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available